文献
J-GLOBAL ID:202202274143804406
整理番号:22A1025355
lncRNA DUXAP8/miR-29a/PIK3CAネットワークの標的化は化学療法抵抗性B細胞急性リンパ芽球性白血病においてPI3K-AKT-mTORシグナリングを介してドキソルビシン化学感受性を回復し,イノツズマブオゾガマイシンと相乗作用する【JST・京大機械翻訳】
Targeting the lncRNA DUXAP8/miR-29a/PIK3CA Network Restores Doxorubicin Chemosensitivity via PI3K-AKT-mTOR Signaling and Synergizes With Inotuzumab Ozogamicin in Chemotherapy-Resistant B-Cell Acute Lymphoblastic Leukemia
著者 (10件):
Zhang Li
(1Department of Oral and Maxillofacial Surgery, The Affiliated Stomatology Hospital of Southwest Medical University, Luzhou, China)
,
Zhang Li
(2Orofacial Reconstruction and Regeneration Laboratory, The Affiliated Stomatology Hospital of Southwest Medical University, Luzhou, China)
,
Zhang Li
(3Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, China)
,
Zhou Shixia
(4Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, China)
,
Zhou Shixia
(5Stem Cell Laboratory, The Affiliated Hospital of Southwest Medical University, Luzhou, China)
,
Zhou Tiejun
(6Department of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, China)
,
Li Xiaoming
(4Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, China)
,
Li Xiaoming
(5Stem Cell Laboratory, The Affiliated Hospital of Southwest Medical University, Luzhou, China)
,
Tang Junling
(4Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, China)
,
Tang Junling
(5Stem Cell Laboratory, The Affiliated Hospital of Southwest Medical University, Luzhou, China)
資料名:
Frontiers in Oncology (Web)
(Frontiers in Oncology (Web))
巻:
12
ページ:
773601
発行年:
2022年
JST資料番号:
U7089A
ISSN:
2234-943X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
スイス (CHE)
言語:
英語 (EN)